FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Senate deadlock continues as Democrats refuse to end the government shutdown without concessions on healthcare and other priorities.
Eagles trade for Jets CB Michael Carter II to bolster their secondary for a title defense.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Senate deadlock continues as Democrats refuse to end the government shutdown without concessions on healthcare and other priorities.
Eagles trade for Jets CB Michael Carter II to bolster their secondary for a title defense.